- Home
- Companies
- canada alberta
- drug development
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Manufacturing, Other
- Agriculture
- Environmental
- University / Academia / Research
- Health and Safety
- Food and Beverage
- Energy
- Waste and Recycling
- Air and Climate
- Government
- Publishing / Media / Marketing
- Glassware
- Metal
- Plastics & Resins
- Water and Wastewater
- Soil and Groundwater
- Construction & Construction Materials
- Mining
- Banking & Finance / Insurance / Legal
- Aerospace & Air Transport
- Forestry & Wood
- Retail
- Packaging
- Paint
- Pulp & Paper
- Oil, Gas & Refineries
Drug Development Suppliers Serving Canada Alberta
291 companies found
based inSayreville, NEW JERSEY (USA)
HERMLE centrifuges have established themselves as indispensable tools for DNA analysis, drug development in the pharmaceutical industry and even standard blood tests at your GP's surgery. We are also well and truly “at home” in the fields of ...
based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
Therefore, monitoring autophagy can provide valuable insights into understanding human pathological mechanisms, developing new drugs, and exploring ways to control autophagy. ...
based inEugene, OREGON (USA)
InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts. An expert in CRISPR genome ...
based inMalvern, DELAWARE (USA)
Founded in 1996, LifeSensors, Inc. helps life scientists innovate in basic research, drug discovery and diagnostics. LifeSensors pioneered the SUMO-fusion system for high quality protein expression. Development of cutting-edge tools for ubiquitin ...
based inKaiseraugst, SWITZERLAND
Solvias is a world leader in contract research, development and manufacturing (CRO/CDMO). The industries we serve include pharmaceuticals, biotech, medical devices and cosmetics. We provide integrated analytical services and solutions to the ...
We understand that early assessment of a protein biopharmaceutical’s stability can be invaluable, even during pre-development. For drug substances and drug products all stability aspects can ...
based inTokyo, JAPAN
Mitsubishi Chemical Europe GmbH is a wholly-owned subsidiary of Mitsubishi Chemical Corporation, headquartered in Tokyo, Japan. In its role as the Regional Headquarters for Europe it promotes the exchange between each group company in Europe and ...
based inEdinburgh, UNITED KINGDOM
Manus Neurodynamica is revolutionising health care management by developing and patenting neuroscience technologies that record recognised biomarkers of neuromotor impairments which can radically improve patient diagnosis and disease monitoring. Our ...
based inLYON, FRANCE
Founded in December 2013, Adjuvatis is specialized in the development, manufacturing and formulation of a safe-by-design delivery system, called i-Particles®. Based on fully metabolizable ans biocompatible particles, this technology was initially ...
based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in NSCLC for EGFR, HER2, KRAS and BRAF genes are ...
based inOceanside, CALIFORNIA (USA)
Eidogen-Sertanty is dedicated to improving health, medicine, and general well-being. For the last 20-years, Eidogen-Sertanty has helped to expedite the discovery and development of many new, safer medicines through collaborative project team ...
based inKöln, GERMANY
Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking single cell analysis techniques in clinical diagnosis, drug development, and health management. Singleron Biotechnologies is an innovative ...
based inTeltow, GERMANY
Hielscher Ultrasonics specializes in the design and manufacturing of high power ultrasonic homogenizers for lab, bench-top and production level. Ultrasonic power is an effective and energy-efficient means to apply high shear and intense stress to ...
based inAbingdon, UNITED KINGDOM
Founded on innovation and operating with an entrepreneurial flair, Oxford Optronix is a global pioneer in design, development and manufacture of sophisticated instrumentation for the life sciences. Our products are designed, developed and ...
based inParis, FRANCE
Qynapse, through QyScore, brings groundbreaking peace of mind to the global fight against CNS disease. Qyscore is a medical device software FDA-cleared – class II and CE-marked – class IIa (CE BSI). Qyscore is a medical device software FDA-cleared ...
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS disease and create the potential for earlier ...
based inMunich, GERMANY
Nanion combines trusted scientific support with exceptional instrumentation to accelerate successful drug development and scientific discoveries. Our broad range of applications and user-friendly assay solutions can be tailored to your needs to ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
PF-4878691 (3M-852A) is an orally active TLR7 agonist. PF-4878691 has the innate immune response activity, antiviral efficacy against HCV, and can be used for the research of ...
based inHertfordshire, UNITED KINGDOM
Fluidic Sciences Ltd specializes in microfluidic technologies for accelerating protein interaction analysis and single-cell screening. Their flagship product, Fluidity One-M, enables rapid measurements of binding affinity, concentration, ...
Fluidic Sciences Ltd. offers the Fluidity One-M instrument, integrated with Microfluidic Diffusional Sizing (MDS) technology, specifically engineered for in-solution analysis of antibodies and their targets throughout various stages of ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
ZW49 is a HER2-targeted antibody drug conjugate (ADC) developed using Zymeworks’ proprietary Azymetric™ and ZymeLink™ platforms. ZW49 is currently being evaluated in a Phase 1 clinical trial as a ...
based inVillejuif, FRANCE
Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...
An increasing number of laboratories are using electronic records and electronic signatures for exchanging and storing data. Electronic documentation offers many benefits, including increased efficiency and productivity when storing data and easier ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceuticals specializes in the invention and development of specialty pharmaceutical products and novel formulation technologies. We provide formulation, analytical, and manufacturing services to pharmaceutical companies, working ...
Ascendia develops and evaluates a variety of formulations for preclinical non-GLP and GLP studies. We understand the needs of companies with an exciting compound in the discovery pipeline, but with limited amounts of ...